| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32327610P | 2010-04-12 | 2010-04-12 | |
| US38909010P | 2010-10-01 | 2010-10-01 |
| Publication Number | Publication Date |
|---|---|
| SG10201808661XAtrue SG10201808661XA (en) | 2018-11-29 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012075834ASG184830A1 (en) | 2010-04-12 | 2011-04-12 | Method of treating obesity using antioxidant inflammation modulators |
| SG10201808661XASG10201808661XA (en) | 2010-04-12 | 2011-04-12 | Method of treating obesity using antioxidant inflammation modulators |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012075834ASG184830A1 (en) | 2010-04-12 | 2011-04-12 | Method of treating obesity using antioxidant inflammation modulators |
| Country | Link |
|---|---|
| US (3) | US10105372B2 (en) |
| EP (1) | EP2558105B1 (en) |
| JP (1) | JP5990160B2 (en) |
| KR (1) | KR101819699B1 (en) |
| CN (1) | CN102939089B (en) |
| AU (1) | AU2011240690C1 (en) |
| BR (1) | BR112012026112B1 (en) |
| CA (1) | CA2795320C (en) |
| CL (1) | CL2012002859A1 (en) |
| CY (1) | CY1122480T1 (en) |
| DK (1) | DK2558105T3 (en) |
| EA (1) | EA026567B1 (en) |
| ES (1) | ES2768204T3 (en) |
| HR (1) | HRP20192291T1 (en) |
| HU (1) | HUE047994T2 (en) |
| IL (1) | IL222273B (en) |
| LT (1) | LT2558105T (en) |
| ME (1) | ME03713B (en) |
| MX (1) | MX357596B (en) |
| MY (1) | MY163031A (en) |
| NZ (1) | NZ602826A (en) |
| PH (1) | PH12012502041B1 (en) |
| PL (1) | PL2558105T3 (en) |
| PT (1) | PT2558105T (en) |
| RS (1) | RS59850B1 (en) |
| SG (2) | SG184830A1 (en) |
| SI (1) | SI2558105T1 (en) |
| SM (1) | SMT202000086T1 (en) |
| TW (1) | TWI558724B (en) |
| WO (1) | WO2011130302A2 (en) |
| ZA (1) | ZA201207518B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6326507B1 (en) | 1998-06-19 | 2001-12-04 | Trustees Of Dartmouth College | Therapeutic compounds and methods of use |
| KR101780382B1 (en) | 2008-01-11 | 2017-10-10 | 리타 파마슈티컬스 잉크. | Synthetic triterpenoids and methods of use in the treatment of disease |
| CN102164941B (en) | 2008-04-18 | 2015-05-27 | 里亚塔医药公司 | Antioxidant inflammation regulator oleanolic acid derivative having saturated C ring |
| CN104250280A (en) | 2008-04-18 | 2014-12-31 | 里亚塔医药公司 | Antioxidant Inflammation Modulators: C-17 Homologous Oleanolic Acid Derivatives |
| EA020467B1 (en) | 2008-04-18 | 2014-11-28 | Ритэ Фамэсутикл, Инк. | Compounds having antiinflammatory activity and pharmaceutical composition based thereon |
| PL2276493T3 (en) | 2008-04-18 | 2019-05-31 | Reata Pharmaceuticals Inc | Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17 |
| JP5758801B2 (en) | 2008-07-22 | 2015-08-05 | トラスティーズ・オブ・ダートマス・カレッジＴｒｕｓｔｅｅｓ ｏｆ Ｄａｒｔｍｏｕｔｈ Ｃｏｌｌｅｇｅ | Monocyclic cyanoenone and description of how to use it |
| HUE047994T2 (en) | 2010-04-12 | 2020-05-28 | Reata Pharmaceuticals Inc | Bardoxolone methyl for the treatment of obesity |
| SG191181A1 (en) | 2010-12-17 | 2013-07-31 | Reata Pharmaceuticals Inc | Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators |
| EA026847B1 (en) | 2011-03-11 | 2017-05-31 | Рита Фармасьютикалз, Инк. | C4-monomethyl triterpenoid derivatives and methods of use thereof |
| KR101174701B1 (en)* | 2011-12-29 | 2012-08-17 | 서울대학교산학협력단 | Food composition, pharmaceutical composition and animal medicine against obesity containing gingerenone a |
| EA030468B1 (en) | 2012-04-27 | 2018-08-31 | Рита Фармасьютикалз, Инк. | 2.2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof |
| US9556222B2 (en) | 2012-06-15 | 2017-01-31 | Reata Pharmaceuticals, Inc. | A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof |
| SI2892912T1 (en) | 2012-09-10 | 2019-07-31 | Reata Pharmaceuticals, Inc. | C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof |
| CN104936972A (en) | 2012-09-10 | 2015-09-23 | 艾伯维公司 | Glycyrrhetinic acid derivatives with anti-inflammatory activity |
| US9278912B2 (en) | 2012-09-10 | 2016-03-08 | Reata Pharmaceuticals, Inc. | C13-hydroxy derivatives of oleanolic acid and methods of use thereof |
| US9512094B2 (en) | 2012-09-10 | 2016-12-06 | Reata Pharmaceuticals, Inc. | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof |
| LT2900230T (en) | 2012-09-27 | 2019-01-10 | The Children`S Medical Center Corporation | COMPOUNDS FOR DETECTION AND USE |
| US9796752B2 (en) | 2013-03-19 | 2017-10-24 | Daiichi Sankyo Company, Limited | Terpenoid derivatives |
| TW201936625A (en) | 2013-04-24 | 2019-09-16 | 美商艾伯維有限公司 | 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof |
| JP6564372B2 (en)* | 2013-08-23 | 2019-08-21 | リアタ ファーマシューティカルズ インコーポレイテッド | Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof |
| EP3097089B1 (en) | 2014-01-24 | 2021-02-24 | Reata Pharmaceuticals, Inc. | Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators |
| AU2015256178B2 (en) | 2014-05-05 | 2020-02-27 | The Board Of Regents Of The University Of Texas System | Methods and compositions comprising ursolic acid and/or resveratrol for treating obesity, diabetes, or cancer |
| US10208082B2 (en) | 2014-09-10 | 2019-02-19 | Daiichi Sankyo Company, Limited | Sustained-release pharmaceutical composition for treatment and prevention of eye disease |
| NZ734292A (en) | 2015-02-12 | 2022-09-30 | Reata Pharmaceuticals Inc | Imidazolyl tricyclic enones as antioxidant inflammation modulators |
| CN105017374B (en)* | 2015-07-20 | 2017-03-01 | 山西大学 | A kind of oleanolic acid lactone analog derivative and its preparation method and application |
| US20170056373A1 (en)* | 2015-09-01 | 2017-03-02 | Syracuse University | Ghrelin o-acyltransferase inhibitors |
| US11584775B2 (en) | 2015-09-23 | 2023-02-21 | Reata Pharmaceuticals, Inc. | C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses |
| WO2018047175A1 (en)* | 2016-09-08 | 2018-03-15 | Regenera Pharma Ltd. | Compositions comprising triterpenoids and uses thereof for treating optic neuropathy |
| WO2018089539A1 (en) | 2016-11-08 | 2018-05-17 | Reata Pharmaceuticals, Inc. | Methods of treating alport syndrome using bardoxolone methyl or analogs thereof |
| TWI831738B (en) | 2016-12-16 | 2024-02-11 | 美商瑞塔醫藥有限責任公司 | PYRIMIDINE TRICYCLIC ENONE DERIVATIVES FOR INHIBITION OF RORγ AND OTHER USES |
| CN112654610B (en) | 2018-06-15 | 2024-12-24 | 里亚塔医药公司 | Pyrazole and imidazole compounds for inhibition of IL-17 and RORγ |
| WO2019246461A1 (en) | 2018-06-20 | 2019-12-26 | Reata Pharmaceuticals, Inc. | Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of treating diseases or disorders therewith |
| JP2023524035A (en)* | 2020-04-29 | 2023-06-08 | バイオエイジ ラブス， インコーポレイテッド | Hypoxia-inducible factor prolyl hydroxylase inhibitors for treating age-related conditions |
| WO2024145502A1 (en)* | 2022-12-29 | 2024-07-04 | The Board Of Regents Of The University Of Texas System | Synthetic triterpenoids and compositions thereof in weight management, skeletal muscle function, and appetite suppression |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ191586A (en) | 1978-10-10 | 1981-10-19 | Sterling Drug Inc | Cyanoketones derived from glycyrrhetinic acid and pharmaceutical compositions |
| US4395423A (en) | 1978-10-10 | 1983-07-26 | Sterling Drug Inc. | Polycyclic cyanoketones |
| US6025395A (en) | 1994-04-15 | 2000-02-15 | Duke University | Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders |
| US6326507B1 (en) | 1998-06-19 | 2001-12-04 | Trustees Of Dartmouth College | Therapeutic compounds and methods of use |
| US6369101B1 (en) | 1999-02-26 | 2002-04-09 | Regents Of The University Of Minnesota | Therapeutic method to treat herpes virus infection |
| EP1178952B1 (en) | 1999-05-14 | 2007-08-22 | Nereus Pharmaceuticals, Inc. | Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators |
| US6890946B2 (en) | 1999-12-23 | 2005-05-10 | Indiana University Research And Technology Corporation | Use of parthenolide to inhibit cancer |
| WO2002003996A1 (en) | 2000-07-12 | 2002-01-17 | RAJKUMAR, Sujatha | Use of dammarane-type tritepenoid saporins |
| EP1322661A1 (en) | 2000-09-29 | 2003-07-02 | Regents Of The University Of Minnesota | Triterpenes having fungicidal activity against yeast |
| US6878751B1 (en) | 2000-10-19 | 2005-04-12 | Imperial College Of Science Technology And Medicine | Administration of resveratrol to treat inflammatory respiratory disorders |
| US7435755B2 (en) | 2000-11-28 | 2008-10-14 | The Trustees Of Dartmouth College | CDDO-compounds and combination therapies thereof |
| AU2002243246A1 (en) | 2000-11-28 | 2002-06-24 | Board Of Regents, The University Of Texas System | Cddo-compounds and combination therapies thereof |
| WO2002076472A2 (en)* | 2001-03-23 | 2002-10-03 | Shire Biochem Inc. | Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs |
| CN1636058B (en) | 2001-05-14 | 2011-06-08 | 龚大为 | Novel alanine aminotransferase and method of use thereof |
| DK1465615T3 (en) | 2002-01-15 | 2012-11-12 | Dartmouth College | Tricyclic bisonone derivatives and methods for their use |
| EP1507541A4 (en) | 2002-05-13 | 2009-06-03 | Dartmouth College | INHIBITORS AND METHODS OF USE THEREOF |
| EP1457206A1 (en) | 2003-03-13 | 2004-09-15 | Fournier Laboratories Ireland Limited | Combined use of a fibrate and orlistat for the treatment of obesity |
| US20050014730A1 (en) | 2003-04-02 | 2005-01-20 | Carlson Robert M. | Anti-fungal formulation of triterpene and essential oil |
| WO2004099246A2 (en) | 2003-05-09 | 2004-11-18 | Novo Nordisk A/S | Peptides for use in treating obesity |
| RU2005133970A (en)* | 2003-05-09 | 2007-06-20 | Ново Нордиск А/С (DK) | PEPTIDES USED FOR TREATING OBESITY |
| EP1633208A1 (en) | 2003-05-27 | 2006-03-15 | DSM IP Assets B.V. | Novel nutraceutical compositions and use thereof |
| US20050208151A1 (en) | 2003-10-30 | 2005-09-22 | Entelos, Inc. | Treatment of rheumatoid arthritis with FLIP antagonists |
| US8288439B2 (en) | 2003-11-04 | 2012-10-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods and compositions for the inhibition of HIV-1 replication |
| PL1803468T3 (en) | 2003-12-22 | 2012-05-31 | Novartis Ag | Agents for treatment of glaucomatours retinopathy and optic neuropathy |
| JP2005314381A (en) | 2004-03-30 | 2005-11-10 | Anges Mg Inc | Prophylactic/therapeutic/ameliorating agent for proliferative nephropathy |
| WO2005113761A2 (en) | 2004-04-19 | 2005-12-01 | University Of Maryland, Baltimore | Novel alanine transaminase enzymes and methods of use |
| US7772195B2 (en) | 2004-07-29 | 2010-08-10 | Board Of Trustees Of Michigan State University | Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia |
| JP5087400B2 (en) | 2004-09-07 | 2012-12-05 | パシフィック アロー リミテッド | Antitumor compounds having an angeloyl group |
| AU2006265113A1 (en) | 2005-07-01 | 2007-01-11 | The Johns Hopkins University | Compositions and methods for the treatment or prevention of disorders relating to oxidative stress |
| WO2007127791A2 (en) | 2006-04-25 | 2007-11-08 | The Administrators Of The Tulane Educational Fund | New pharmacological method for treatment of neuropathic pain |
| JP5610766B2 (en) | 2006-06-27 | 2014-10-22 | ウェリントン ラボラトリーズ インコーポレイティッド | Glycyrrhetinic acid derivative |
| JP2008110962A (en) | 2006-08-02 | 2008-05-15 | Santen Pharmaceut Co Ltd | PREVENTING OR TREATING AGENT OF KERATOCONJUNCTIVAL TROUBLE, CONTAINING Nrf2-ACTIVATING SUBSTANCE AS ACTIVE INGREDIENT |
| WO2008016095A1 (en) | 2006-08-02 | 2008-02-07 | Santen Pharmaceutical Co., Ltd. | PREVENTIVE OR REMEDY FOR KERATOCONJUNCTIVAL DISORDERS CONTAINING Nrf2 ACTIVATOR AS THE ACTIVE INGREDIENT |
| US8299046B2 (en) | 2006-11-17 | 2012-10-30 | Trustees Of Dartmouth College | Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth |
| CA2670099A1 (en) | 2006-11-17 | 2008-05-29 | Trustees Of Dartmouth College | Synthesis and biological activities of new tricyclic-bis-enones (tbes) |
| JP2008247898A (en) | 2007-03-08 | 2008-10-16 | Santen Pharmaceut Co Ltd | Agent for preventing or treating oxidative-stress-associated eye disease, containing triterpenoid as active ingredient |
| WO2008136838A1 (en) | 2007-05-04 | 2008-11-13 | Trustees Of Dartmouth College | Novel amide derivatives of cddo and methods of use thereof |
| US8088824B2 (en) | 2007-08-15 | 2012-01-03 | Reata Pharmaceuticals Inc. | Forms of CDDO methyl ester |
| US20090048205A1 (en) | 2007-08-15 | 2009-02-19 | Colin Meyer | Combination therapy with synthetic triterpenoids and gemcitabine |
| US9012439B2 (en) | 2007-10-29 | 2015-04-21 | University Of Rochester | Use of electrophilic compounds for inducing platelet production or maintaining platelet function |
| KR101780382B1 (en)* | 2008-01-11 | 2017-10-10 | 리타 파마슈티컬스 잉크. | Synthetic triterpenoids and methods of use in the treatment of disease |
| US8071632B2 (en)* | 2008-04-18 | 2011-12-06 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: novel derivatives of oleanolic acid |
| CN102164941B (en) | 2008-04-18 | 2015-05-27 | 里亚塔医药公司 | Antioxidant inflammation regulator oleanolic acid derivative having saturated C ring |
| EA020467B1 (en)* | 2008-04-18 | 2014-11-28 | Ритэ Фамэсутикл, Инк. | Compounds having antiinflammatory activity and pharmaceutical composition based thereon |
| PL2276493T3 (en) | 2008-04-18 | 2019-05-31 | Reata Pharmaceuticals Inc | Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17 |
| CN104250280A (en) | 2008-04-18 | 2014-12-31 | 里亚塔医药公司 | Antioxidant Inflammation Modulators: C-17 Homologous Oleanolic Acid Derivatives |
| JP5758801B2 (en) | 2008-07-22 | 2015-08-05 | トラスティーズ・オブ・ダートマス・カレッジＴｒｕｓｔｅｅｓ ｏｆ Ｄａｒｔｍｏｕｔｈ Ｃｏｌｌｅｇｅ | Monocyclic cyanoenone and description of how to use it |
| SMT201900432T1 (en) | 2009-02-13 | 2019-09-09 | Reata Pharmaceuticals Inc | Delayed release, oral dosage compositions that contain amorphous cddo-me |
| HUE047994T2 (en)* | 2010-04-12 | 2020-05-28 | Reata Pharmaceuticals Inc | Bardoxolone methyl for the treatment of obesity |
| US8618125B2 (en) | 2011-01-14 | 2013-12-31 | Heptiva LLC | Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance |
| CN102875634B (en) | 2012-10-24 | 2014-08-20 | 苏州晶云药物科技有限公司 | Crystal forms of 2-cyano-3, 12-dioxooleana-1, 9(11)-diene-28-oic acid methyl ester |
| CN102887936A (en) | 2012-10-24 | 2013-01-23 | 苏州晶云药物科技有限公司 | Crystal forms of 2-cyano-3,12-dioxoolean-1,9(11)-diene-28-oic acid methyl ester |
| Publication | Publication Date | Title |
|---|---|---|
| SG10201808661XA (en) | Method of treating obesity using antioxidant inflammation modulators | |
| CA2865011C (en) | Methods and compositions for treating huntington's disease | |
| EP4474389A3 (en) | Compounds and methods for modulating angiotensinogen expression | |
| MX2012000434A (en) | Method of wound healing and scar modulation. | |
| SG10201907588XA (en) | Androgen Receptor Modulators And Uses Thereof | |
| CA2900779C (en) | Compositions and methods for treating neurodegenerative diseases and cardiomyopathy | |
| AU2011328009A8 (en) | Compounds and methods for treating pain | |
| SG10201903119QA (en) | Polypeptide vaccine | |
| AU2016219704A1 (en) | Anti-Notch1 antibodies | |
| MY175979A (en) | Certain chemical entities, compositions and methods | |
| MX2011007930A (en) | Crystalline insulin-conjugates. | |
| IN2012DN03883A (en) | ||
| MX2013008390A (en) | Preparation of metal-triazolate frameworks. | |
| WO2012125544A3 (en) | Necroptosis inhibitors and methods of use therefor | |
| PH12014500904B1 (en) | Antibody formulations and methods | |
| MX349948B (en) | Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae. | |
| AU2018253600A1 (en) | Dosage forms and therapeutic uses of l-4-chlorokynurenine | |
| EP2597949A4 (en) | Sub-micron compositions | |
| MX2014014814A (en) | Pharmaceutical composition for treating inflammation and pain. | |
| MX343409B (en) | Pharmaceutical combinations including anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders. | |
| WO2012082942A3 (en) | Neuropeptide analogs, compositions, and methods for treating pain | |
| MX2011010046A (en) | Diaminopteridine derivatives. | |
| WO2012024670A3 (en) | Composition and methods for treating glioblastoma | |
| WO2013049272A3 (en) | Composition and method for treatment of symptoms associated with various skin conditions | |
| GEP201706614B (en) | Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process |